Somatuline Autogel® is a ready-to-use sustained release formulation of the peptide lanreotide with a unique and innovative controlled release mechanism. Andy Lewis interviewed Joël Richard, VP Peptides at Ipsen, on the background of its development, how it works, and how it is manufactured.
CRS Vision Statement:Visionary leadership in delivery science and technology. CRS Mission Statement:CRS is an international, multidisciplinary society dedicated to delivery science and technology.
DDTR Special Issue: RNA Interference-based Therapeutics and DiagnosticsIt is an exciting time in the RNA interference (RNAi) field. We are in the midst of a rich period of clinical translation made possible by advances in delivery science and technology. Over the past few years alone, human of proof of concept for RNAi has been demonstrated using systemically administered small interfering RNA (siRNA) therapeutics. Read more